fanta.bio Sample: CNhs10620
- Species
- human
- CRE Type
- ELA
- Cluster
- 3
- Cell Type Class
- Digestive_tract
18350 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1212 / 16902 (7.2%) | 399 / 169020 (0.2%) | −324.0 | −324.0 | 30.38 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1722 / 16902 (10.2%) | 721 / 169020 (0.4%) | −324.0 | −324.0 | 23.88 |
| HIF1A SRX11007095 | HK-2 Kidney | 2237 / 16902 (13.2%) | 946 / 169020 (0.6%) | −324.0 | −324.0 | 23.65 |
| HIF1A SRX20663235 | HK-2 Kidney | 516 / 16902 (3.1%) | 253 / 169020 (0.1%) | −324.0 | −324.0 | 20.40 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1575 / 16902 (9.3%) | 812 / 169020 (0.5%) | −324.0 | −324.0 | 19.40 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2234 / 16902 (13.2%) | 1247 / 169020 (0.7%) | −324.0 | −324.0 | 17.91 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2130 / 16902 (12.6%) | 1222 / 169020 (0.7%) | −324.0 | −324.0 | 17.43 |
| SCML2 SRX644728 | 293 Kidney | 1335 / 16902 (7.9%) | 804 / 169020 (0.5%) | −324.0 | −324.0 | 16.60 |
| MED1 SRX9419945 | BT-474 Breast | 3722 / 16902 (22.0%) | 2801 / 169020 (1.7%) | −324.0 | −324.0 | 13.29 |
| MED1 SRX9419944 | BT-474 Breast | 3651 / 16902 (21.6%) | 2759 / 169020 (1.6%) | −324.0 | −324.0 | 13.23 |
| BRD4 SRX9419935 | BT-474 Breast | 3684 / 16902 (21.8%) | 2814 / 169020 (1.7%) | −324.0 | −324.0 | 13.09 |
| MED1 SRX9419946 | BT-474 Breast | 3762 / 16902 (22.3%) | 2969 / 169020 (1.8%) | −324.0 | −324.0 | 12.67 |
| MED1 SRX9419947 | BT-474 Breast | 3673 / 16902 (21.7%) | 2911 / 169020 (1.7%) | −324.0 | −324.0 | 12.62 |
| BRD4 SRX9419937 | BT-474 Breast | 3639 / 16902 (21.5%) | 2893 / 169020 (1.7%) | −324.0 | −324.0 | 12.58 |
| BRD4 SRX9419938 | BT-474 Breast | 3734 / 16902 (22.1%) | 2976 / 169020 (1.8%) | −324.0 | −324.0 | 12.55 |
| BRD4 SRX9419936 | BT-474 Breast | 3767 / 16902 (22.3%) | 3016 / 169020 (1.8%) | −324.0 | −324.0 | 12.49 |
| FOXP1 SRX736067 | LNCAP Prostate | 1559 / 16902 (9.2%) | 1273 / 169020 (0.8%) | −324.0 | −324.0 | 12.25 |
| MYH11 SRX265221 | ME-1 Blood | 772 / 16902 (4.6%) | 657 / 169020 (0.4%) | −324.0 | −324.0 | 11.75 |
| EZH2 SRX2146136 | LNCAP Prostate | 7772 / 16902 (46.0%) | 8231 / 169020 (4.9%) | −324.0 | −324.0 | 9.44 |
| BRD4 SRX736201 | 90-8TL Neural | 5718 / 16902 (33.8%) | 6807 / 169020 (4.0%) | −324.0 | −324.0 | 8.40 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 762 / 16902 (4.5%) | 972 / 169020 (0.6%) | −324.0 | −324.0 | 7.84 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1765 / 16902 (10.4%) | 2740 / 169020 (1.6%) | −324.0 | −324.0 | 6.44 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1604 / 16902 (9.5%) | 3596 / 169020 (2.1%) | −324.0 | −324.0 | 4.46 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 2183 / 16902 (12.9%) | 4896 / 169020 (2.9%) | −324.0 | −324.0 | 4.46 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1949 / 16902 (11.5%) | 5227 / 169020 (3.1%) | −324.0 | −324.0 | 3.73 |
| Epitope tags SRX10549776 | K-562 Blood | 1739 / 16902 (10.3%) | 5068 / 169020 (3.0%) | −324.0 | −324.0 | 3.43 |
| AGO2 SRX4708039 | Hep G2 Liver | 2359 / 16902 (14.0%) | 7287 / 169020 (4.3%) | −324.0 | −324.0 | 3.24 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 2336 / 16902 (13.8%) | 7557 / 169020 (4.5%) | −324.0 | −324.0 | 3.09 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 2065 / 16902 (12.2%) | 6720 / 169020 (4.0%) | −324.0 | −324.0 | 3.07 |
| SREBF2 SRX5359048 | HCC70 Breast | 2268 / 16902 (13.4%) | 7400 / 169020 (4.4%) | −324.0 | −324.0 | 3.06 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 2148 / 16902 (12.7%) | 7054 / 169020 (4.2%) | −324.0 | −324.0 | 3.05 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2824 / 16902 (16.7%) | 9365 / 169020 (5.5%) | −324.0 | −324.0 | 3.02 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 2428 / 16902 (14.4%) | 8256 / 169020 (4.9%) | −324.0 | −324.0 | 2.94 |
| BMI1 SRX7196721 | SF8628 Neural | 2232 / 16902 (13.2%) | 7641 / 169020 (4.5%) | −324.0 | −324.0 | 2.92 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2531 / 16902 (15.0%) | 8800 / 169020 (5.2%) | −324.0 | −324.0 | 2.88 |
| PTEN SRX5416007 | SMMC-7721 Liver | 2343 / 16902 (13.9%) | 8193 / 169020 (4.8%) | −324.0 | −324.0 | 2.86 |
| MECOM SRX23677884 | HNT-34 Blood | 2221 / 16902 (13.1%) | 7802 / 169020 (4.6%) | −324.0 | −324.0 | 2.85 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 2200 / 16902 (13.0%) | 7738 / 169020 (4.6%) | −324.0 | −324.0 | 2.84 |
| WDR5 SRX5416008 | SMMC-7721 Liver | 2322 / 16902 (13.7%) | 8196 / 169020 (4.8%) | −324.0 | −324.0 | 2.83 |
| CDYL2 SRX8321653 | MCF-7 Breast | 2370 / 16902 (14.0%) | 8376 / 169020 (5.0%) | −324.0 | −324.0 | 2.83 |
| MECOM SRX23677885 | HNT-34 Blood | 2238 / 16902 (13.2%) | 7964 / 169020 (4.7%) | −324.0 | −324.0 | 2.81 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 2472 / 16902 (14.6%) | 9005 / 169020 (5.3%) | −324.0 | −324.0 | 2.75 |
| MITF SRX1555436 | 501A Epidermis | 2429 / 16902 (14.4%) | 9181 / 169020 (5.4%) | −324.0 | −324.0 | 2.65 |
| MECOM SRX23677897 | HNT-34 Blood | 2616 / 16902 (15.5%) | 9949 / 169020 (5.9%) | −324.0 | −324.0 | 2.63 |
| Epitope tags SRX8109066 | Gastric cancer cells Digestive tract | 2315 / 16902 (13.7%) | 8933 / 169020 (5.3%) | −324.0 | −324.0 | 2.59 |
| MECOM SRX23677896 | HNT-34 Blood | 2690 / 16902 (15.9%) | 10461 / 169020 (6.2%) | −324.0 | −324.0 | 2.57 |
| 5-mC SRX882965 | LNCAP Prostate | 2937 / 16902 (17.4%) | 11598 / 169020 (6.9%) | −324.0 | −324.0 | 2.53 |
| RUNX1 SRX2513054 | 293 Kidney | 4276 / 16902 (25.3%) | 17304 / 169020 (10.2%) | −324.0 | −324.0 | 2.47 |
| TRP47 SRX4548329 | THP-1 Blood | 3317 / 16902 (19.6%) | 13633 / 169020 (8.1%) | −324.0 | −324.0 | 2.43 |
| 5-mC SRX882970 | LNCAP Prostate | 3615 / 16902 (21.4%) | 15013 / 169020 (8.9%) | −324.0 | −324.0 | 2.41 |
| 5-mC SRX882968 | LNCAP Prostate | 3544 / 16902 (21.0%) | 14881 / 169020 (8.8%) | −324.0 | −324.0 | 2.38 |
| RUNX1 SRX2014504 | Jurkat Blood | 2971 / 16902 (17.6%) | 12494 / 169020 (7.4%) | −324.0 | −324.0 | 2.38 |
| CIC SRX13262055 | Astrocytes Neural | 3861 / 16902 (22.8%) | 16306 / 169020 (9.6%) | −324.0 | −324.0 | 2.37 |
| PBX4 SRX2731658 | PC-3 Prostate | 870 / 16902 (5.1%) | 26628 / 169020 (15.8%) | −324.0 | −324.0 | 0.33 |
| YAP1 SRX757325 | H2052 Lung | 486 / 16902 (2.9%) | 20677 / 169020 (12.2%) | −324.0 | −324.0 | 0.24 |
| YAP1 SRX757326 | H2052 Lung | 387 / 16902 (2.3%) | 18544 / 169020 (11.0%) | −324.0 | −324.0 | 0.21 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 732 / 16902 (4.3%) | 883 / 169020 (0.5%) | −322.4 | −319.6 | 8.29 |
| AGO2 SRX6783958 | Hep G2 Liver | 1501 / 16902 (8.9%) | 4276 / 169020 (2.5%) | −318.7 | −316.0 | 3.51 |
| AGO2 SRX6783957 | Hep G2 Liver | 1513 / 16902 (9.0%) | 4407 / 169020 (2.6%) | −312.6 | −309.9 | 3.43 |
| RORC SRX5359052 | HCC70 Breast | 1637 / 16902 (9.7%) | 5118 / 169020 (3.0%) | −309.5 | −306.7 | 3.20 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2470 / 16902 (14.6%) | 10241 / 169020 (6.1%) | −306.4 | −303.7 | 2.41 |
| ERG SRX063921 | K-562 Blood | 1842 / 16902 (10.9%) | 6356 / 169020 (3.8%) | −304.4 | −301.6 | 2.90 |
| ERG SRX063922 | K-562 Blood | 1914 / 16902 (11.3%) | 6800 / 169020 (4.0%) | −303.0 | −300.3 | 2.81 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 716 / 16902 (4.2%) | 923 / 169020 (0.5%) | −302.4 | −299.7 | 7.76 |
| MECOM SRX23677890 | HNT-34 Blood | 2172 / 16902 (12.9%) | 8462 / 169020 (5.0%) | −298.1 | −295.4 | 2.57 |
| TRIM25 SRX1660872 | Breast cancer cells Breast | 1999 / 16902 (11.8%) | 7465 / 169020 (4.4%) | −293.1 | −290.4 | 2.68 |
| MECOM SRX23677891 | HNT-34 Blood | 2150 / 16902 (12.7%) | 8418 / 169020 (5.0%) | −292.4 | −289.7 | 2.55 |
| BRD1 SRX286203 | RKO Digestive tract | 1394 / 16902 (8.2%) | 4101 / 169020 (2.4%) | −283.5 | −280.8 | 3.40 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 916 / 16902 (5.4%) | 24308 / 169020 (14.4%) | −282.2 | −279.5 | 0.38 |
| RORC SRX5359053 | HCC70 Breast | 1541 / 16902 (9.1%) | 4930 / 169020 (2.9%) | −281.5 | −278.8 | 3.13 |
| ESR1 SRX2897220 | Breast cancer cells Breast | 1861 / 16902 (11.0%) | 6821 / 169020 (4.0%) | −280.1 | −277.4 | 2.73 |
| KAT7 SRX101303 | RKO Digestive tract | 1559 / 16902 (9.2%) | 5051 / 169020 (3.0%) | −279.9 | −277.3 | 3.09 |
| TET2 SRX2014505 | Jurkat Blood | 2992 / 16902 (17.7%) | 14379 / 169020 (8.5%) | −278.8 | −276.2 | 2.08 |
| FOS SRX150478 | MCF 10A Breast | 657 / 16902 (3.9%) | 20206 / 169020 (12.0%) | −278.3 | −275.6 | 0.33 |
| MEAF6 SRX10606586 | GIST-T1 Digestive tract | 1513 / 16902 (9.0%) | 4831 / 169020 (2.9%) | −276.9 | −274.2 | 3.13 |
| BRPF3 SRX796084 | RKO Digestive tract | 1714 / 16902 (10.1%) | 6052 / 169020 (3.6%) | −272.4 | −269.7 | 2.83 |
| BRPF3 SRX796086 | RKO Digestive tract | 1665 / 16902 (9.9%) | 5768 / 169020 (3.4%) | −272.0 | −269.3 | 2.89 |
| ZFX SRX7805372 | 293 Kidney | 1830 / 16902 (10.8%) | 6756 / 169020 (4.0%) | −271.8 | −269.2 | 2.71 |
| BRPF3 SRX796085 | RKO Digestive tract | 1256 / 16902 (7.4%) | 3507 / 169020 (2.1%) | −271.5 | −268.9 | 3.58 |
| GRHL3 SRX2582162 | NHEK Epidermis | 1304 / 16902 (7.7%) | 3759 / 169020 (2.2%) | −271.4 | −268.8 | 3.47 |
| FOS SRX150477 | MCF 10A Breast | 643 / 16902 (3.8%) | 19678 / 169020 (11.6%) | −268.8 | −266.2 | 0.33 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 640 / 16902 (3.8%) | 19516 / 169020 (11.5%) | −265.3 | −262.7 | 0.33 |
| CHD6 SRX17709200 | C4-2 Prostate | 1845 / 16902 (10.9%) | 6951 / 169020 (4.1%) | −265.2 | −262.6 | 2.65 |
| SS18 SRX3468047 | Fibroblasts Others | 681 / 16902 (4.0%) | 20129 / 169020 (11.9%) | −264.2 | −261.6 | 0.34 |
| GATA3 SRX190194 | SK-N-SH Neural | 637 / 16902 (3.8%) | 19414 / 169020 (11.5%) | −263.7 | −261.1 | 0.33 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 948 / 16902 (5.6%) | 24080 / 169020 (14.2%) | −261.9 | −259.3 | 0.39 |
| MEAF6 DRX234811 | 293 Kidney | 1897 / 16902 (11.2%) | 7354 / 169020 (4.4%) | −260.1 | −257.5 | 2.58 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 572 / 16902 (3.4%) | 654 / 169020 (0.4%) | −259.5 | −256.9 | 8.75 |
| CHD6 SRX17709201 | C4-2 Prostate | 1775 / 16902 (10.5%) | 6623 / 169020 (3.9%) | −258.6 | −256.0 | 2.68 |
| TET2 SRX1427029 | 293 Kidney | 1524 / 16902 (9.0%) | 5154 / 169020 (3.0%) | −256.9 | −254.4 | 2.96 |
| TP53 SRX19538279 | Osteoblasts Bone | 445 / 16902 (2.6%) | 318 / 169020 (0.2%) | −255.0 | −252.5 | 13.99 |
| PHF6 SRX11508321 | G-401 Kidney | 1781 / 16902 (10.5%) | 6741 / 169020 (4.0%) | −253.4 | −250.9 | 2.64 |
| JUN SRX17561461 | LPS141 Adipocyte | 361 / 16902 (2.1%) | 14438 / 169020 (8.5%) | −252.3 | −249.8 | 0.25 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 401 / 16902 (2.4%) | 229 / 169020 (0.1%) | −250.9 | −248.3 | 17.51 |
| KMT2A SRX2281249 | SEM Blood | 2178 / 16902 (12.9%) | 9363 / 169020 (5.5%) | −249.3 | −246.8 | 2.33 |
| HEXIM1 SRX1177905 | HCT 116 Digestive tract | 2074 / 16902 (12.3%) | 8759 / 169020 (5.2%) | −244.9 | −242.3 | 2.37 |
| SUZ12 SRX10184494 | K-562 Blood | 2746 / 16902 (16.2%) | 13442 / 169020 (8.0%) | −242.5 | −240.0 | 2.04 |
| FOS SRX4192880 | MCF 10A Breast | 473 / 16902 (2.8%) | 16047 / 169020 (9.5%) | −241.9 | −239.3 | 0.29 |
| SMARCA2 SRX8119677 | MeT-5A Others | 438 / 16902 (2.6%) | 15441 / 169020 (9.1%) | −241.3 | −238.8 | 0.28 |
| KMT2A SRX2323891 | 293 Kidney | 1162 / 16902 (6.9%) | 3352 / 169020 (2.0%) | −240.8 | −238.2 | 3.47 |
| SREBF2 SRX5359049 | HCC70 Breast | 1395 / 16902 (8.3%) | 4631 / 169020 (2.7%) | −240.7 | −238.2 | 3.01 |
| ATF3 SRX2207918 | CS1AN Epidermis | 2508 / 16902 (14.8%) | 11796 / 169020 (7.0%) | −240.6 | −238.1 | 2.13 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 603 / 16902 (3.6%) | 18056 / 169020 (10.7%) | −238.7 | −236.2 | 0.33 |
| EP300 SRX2671813 | Fibroblasts Others | 175 / 16902 (1.0%) | 10470 / 169020 (6.2%) | −238.5 | −236.0 | 0.17 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 951 / 16902 (5.6%) | 23278 / 169020 (13.8%) | −238.1 | −235.6 | 0.41 |
| MYOCD SRX5598318 | A549 Lung | 1923 / 16902 (11.4%) | 7932 / 169020 (4.7%) | −236.2 | −233.7 | 2.42 |
| TCF12 SRX190356 | SK-N-SH Neural | 808 / 16902 (4.8%) | 21115 / 169020 (12.5%) | −236.1 | −233.6 | 0.38 |
| MEAF6 DRX300417 | 293 Kidney | 1698 / 16902 (10.0%) | 6518 / 169020 (3.9%) | −235.4 | −232.9 | 2.61 |
| MethylCap SRX014767 | NB-4 Blood | 1925 / 16902 (11.4%) | 8024 / 169020 (4.7%) | −231.7 | −229.2 | 2.40 |
| Epitope tags SRX2867680 | 293 Kidney | 2286 / 16902 (13.5%) | 10451 / 169020 (6.2%) | −231.3 | −228.9 | 2.19 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1580 / 16902 (9.3%) | 5859 / 169020 (3.5%) | −231.2 | −228.7 | 2.70 |
| BCOR SRX10184493 | K-562 Blood | 2379 / 16902 (14.1%) | 11101 / 169020 (6.6%) | −231.0 | −228.6 | 2.14 |
| ZFX SRX7805370 | 293 Kidney | 1323 / 16902 (7.8%) | 4360 / 169020 (2.6%) | −230.3 | −227.8 | 3.03 |
| Epitope tags SRX7276677 | 293 Kidney | 2879 / 16902 (17.0%) | 14722 / 169020 (8.7%) | −229.6 | −227.1 | 1.96 |
| TP53 SRX19538274 | U2OS Bone | 357 / 16902 (2.1%) | 193 / 169020 (0.1%) | −227.7 | −225.3 | 18.50 |
| TFEB SRX6743819 | iPS cells Pluripotent stem cell | 1652 / 16902 (9.8%) | 6380 / 169020 (3.8%) | −226.3 | −223.8 | 2.59 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 675 / 16902 (4.0%) | 18719 / 169020 (11.1%) | −225.1 | −222.6 | 0.36 |
| ING5 SRX286202 | RKO Digestive tract | 1443 / 16902 (8.5%) | 5136 / 169020 (3.0%) | −224.4 | −222.0 | 2.81 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 546 / 16902 (3.2%) | 732 / 169020 (0.4%) | −224.3 | −221.9 | 7.46 |
| GRHL3 SRX2582161 | NHEK Epidermis | 1053 / 16902 (6.2%) | 2976 / 169020 (1.8%) | −223.2 | −220.7 | 3.54 |
| JUNB SRX8488073 | SUM 229PE Breast | 556 / 16902 (3.3%) | 16712 / 169020 (9.9%) | −220.5 | −218.1 | 0.33 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 780 / 16902 (4.6%) | 1688 / 169020 (1.0%) | −219.6 | −217.2 | 4.62 |
| CXXC1 SRX1424886 | SEM Blood | 1591 / 16902 (9.4%) | 6123 / 169020 (3.6%) | −218.8 | −216.4 | 2.60 |
| Epitope tags DRX443510 | 293 Kidney | 1578 / 16902 (9.3%) | 6062 / 169020 (3.6%) | −217.6 | −215.1 | 2.60 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 893 / 16902 (5.3%) | 21672 / 169020 (12.8%) | −216.9 | −214.5 | 0.41 |
| Epitope tags SRX2255894 | 293 Kidney | 1491 / 16902 (8.8%) | 5547 / 169020 (3.3%) | −216.4 | −214.0 | 2.69 |
| Epitope tags SRX10549778 | K-562 Blood | 1236 / 16902 (7.3%) | 4049 / 169020 (2.4%) | −216.3 | −213.9 | 3.05 |
| TP53 SRX19538276 | U2OS Bone | 352 / 16902 (2.1%) | 213 / 169020 (0.1%) | −215.5 | −213.1 | 16.53 |
| DOT1L SRX10606582 | GIST-T1 Digestive tract | 1840 / 16902 (10.9%) | 7771 / 169020 (4.6%) | −215.5 | −213.1 | 2.37 |
| LEO1 SRX1873456 | SEM Blood | 1562 / 16902 (9.2%) | 6009 / 169020 (3.6%) | −214.7 | −212.3 | 2.60 |
| Epitope tags SRX15725652 | 293 Kidney | 1991 / 16902 (11.8%) | 8788 / 169020 (5.2%) | −214.7 | −212.3 | 2.27 |
| IRF3 SRX11453858 | Hep G2 Liver | 287 / 16902 (1.7%) | 91 / 169020 (0.1%) | −214.2 | −211.8 | 31.54 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1818 / 16902 (10.8%) | 7651 / 169020 (4.5%) | −214.0 | −211.6 | 2.38 |
| PHF6 SRX11508322 | G-401 Kidney | 1029 / 16902 (6.1%) | 2960 / 169020 (1.8%) | −213.2 | −210.9 | 3.48 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1092 / 16902 (6.5%) | 24338 / 169020 (14.4%) | −212.9 | −210.5 | 0.45 |
| TP53 SRX19538268 | U2OS Bone | 346 / 16902 (2.0%) | 209 / 169020 (0.1%) | −212.0 | −209.6 | 16.55 |
| KMT2A SRX1293531 | MV-4-11 Blood | 2661 / 16902 (15.7%) | 13605 / 169020 (8.0%) | −210.3 | −207.9 | 1.96 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1466 / 16902 (8.7%) | 5489 / 169020 (3.2%) | −210.2 | −207.9 | 2.67 |
| CNOT3 SRX886388 | Colorectal carcinoma Digestive tract | 2077 / 16902 (12.3%) | 9485 / 169020 (5.6%) | −209.2 | −206.8 | 2.19 |
| CTCF SRX12008351 | MCF 10A Breast | 3040 / 16902 (18.0%) | 16489 / 169020 (9.8%) | −208.4 | −206.0 | 1.84 |
| CDK9 SRX20230567 | Ishikawa Uterus | 1901 / 16902 (11.2%) | 8315 / 169020 (4.9%) | −208.1 | −205.7 | 2.29 |
| KAT6A DRX366109 | 293 Kidney | 2207 / 16902 (13.1%) | 10420 / 169020 (6.2%) | −207.5 | −205.2 | 2.12 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1198 / 16902 (7.1%) | 25532 / 169020 (15.1%) | −206.3 | −203.9 | 0.47 |
| Epitope tags SRX15725650 | 293 Kidney | 1768 / 16902 (10.5%) | 7487 / 169020 (4.4%) | −205.4 | −203.0 | 2.36 |
| FOS SRX150517 | MCF 10A Breast | 542 / 16902 (3.2%) | 15976 / 169020 (9.5%) | −205.3 | −202.9 | 0.34 |
| CDK9 SRX20230573 | Ishikawa Uterus | 2301 / 16902 (13.6%) | 11133 / 169020 (6.6%) | −205.2 | −202.8 | 2.07 |
| BCORL1 SRX10184497 | K-562 Blood | 2157 / 16902 (12.8%) | 10121 / 169020 (6.0%) | −205.1 | −202.8 | 2.13 |
| CBFB SRX265218 | ME-1 Blood | 1601 / 16902 (9.5%) | 6422 / 169020 (3.8%) | −204.8 | −202.4 | 2.49 |
| TP53 SRX19538273 | U2OS Bone | 320 / 16902 (1.9%) | 173 / 169020 (0.1%) | −204.1 | −201.8 | 18.50 |
| JUN SRX6582171 | GM07492 Others | 609 / 16902 (3.6%) | 16977 / 169020 (10.0%) | −204.0 | −201.6 | 0.36 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 217 / 16902 (1.3%) | 10341 / 169020 (6.1%) | −203.9 | −201.6 | 0.21 |
| BCORL1 SRX10184498 | K-562 Blood | 2208 / 16902 (13.1%) | 10509 / 169020 (6.2%) | −203.8 | −201.5 | 2.10 |
| KAT6A DRX366108 | 293 Kidney | 1848 / 16902 (10.9%) | 8045 / 169020 (4.8%) | −203.7 | −201.4 | 2.30 |
| TP53 SRX19538275 | U2OS Bone | 323 / 16902 (1.9%) | 183 / 169020 (0.1%) | −202.6 | −200.3 | 17.65 |
| Epitope tags SRX10715360 | HCB1 Blood | 1243 / 16902 (7.4%) | 4299 / 169020 (2.5%) | −201.0 | −198.7 | 2.89 |
| CTCF SRX10975999 | NALM-6 Blood | 3247 / 16902 (19.2%) | 18297 / 169020 (10.8%) | −200.9 | −198.6 | 1.77 |
| JUND SRX190357 | SK-N-SH Neural | 379 / 16902 (2.2%) | 13152 / 169020 (7.8%) | −200.5 | −198.2 | 0.29 |
| BMI1 SRX8726297 | Tumor Others | 1677 / 16902 (9.9%) | 6992 / 169020 (4.1%) | −200.1 | −197.8 | 2.40 |
| MED1 SRX4937340 | HCT 116 Digestive tract | 1704 / 16902 (10.1%) | 7174 / 169020 (4.2%) | −199.7 | −197.4 | 2.38 |
| FOXA1 SRX176862 | MCF-7 Breast | 428 / 16902 (2.5%) | 13944 / 169020 (8.2%) | −199.5 | −197.2 | 0.31 |
| JUNB SRX8488074 | SUM 229PE Breast | 405 / 16902 (2.4%) | 13552 / 169020 (8.0%) | −199.3 | −197.0 | 0.30 |
| FOXA1 SRX4815197 | MCF-7 Breast | 808 / 16902 (4.8%) | 19783 / 169020 (11.7%) | −199.1 | −196.8 | 0.41 |
| TP53 SRX19538267 | U2OS Bone | 317 / 16902 (1.9%) | 181 / 169020 (0.1%) | −198.3 | −196.0 | 17.51 |
| YAP1 SRX5718140 | 293 Kidney | 545 / 16902 (3.2%) | 15767 / 169020 (9.3%) | −197.7 | −195.4 | 0.35 |
| PRRX1 SRX15235713 | Hs 578T Breast | 364 / 16902 (2.2%) | 12804 / 169020 (7.6%) | −197.6 | −195.3 | 0.28 |
| KAT6A SRX20971022 | Fibroblasts Others | 259 / 16902 (1.5%) | 75 / 169020 (0.0%) | −197.6 | −195.3 | 34.53 |
| FOS SRX150476 | MCF 10A Breast | 561 / 16902 (3.3%) | 16004 / 169020 (9.5%) | −197.3 | −195.0 | 0.35 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 297 / 16902 (1.8%) | 11618 / 169020 (6.9%) | −197.0 | −194.7 | 0.26 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1681 / 16902 (9.9%) | 7077 / 169020 (4.2%) | −196.9 | −194.6 | 2.38 |
| PBX3 SRX190343 | SK-N-SH Neural | 683 / 16902 (4.0%) | 17810 / 169020 (10.5%) | −195.6 | −193.3 | 0.38 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 308 / 16902 (1.8%) | 11748 / 169020 (7.0%) | −194.9 | −192.6 | 0.26 |
| FOXA1 SRX176863 | MCF-7 Breast | 396 / 16902 (2.3%) | 13251 / 169020 (7.8%) | −194.6 | −192.3 | 0.30 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 659 / 16902 (3.9%) | 1357 / 169020 (0.8%) | −194.0 | −191.7 | 4.86 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 830 / 16902 (4.9%) | 19897 / 169020 (11.8%) | −193.6 | −191.3 | 0.42 |
| Epitope tags SRX4192708 | MDA-MB-231 Breast | 1132 / 16902 (6.7%) | 3763 / 169020 (2.2%) | −193.5 | −191.2 | 3.01 |
| CTCF SRX12008350 | MCF 10A Breast | 3062 / 16902 (18.1%) | 17107 / 169020 (10.1%) | −192.9 | −190.6 | 1.79 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 642 / 16902 (3.8%) | 17091 / 169020 (10.1%) | −192.8 | −190.5 | 0.38 |
| FOSL2 SRX190296 | SK-N-SH Neural | 415 / 16902 (2.5%) | 13508 / 169020 (8.0%) | −192.7 | −190.5 | 0.31 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 752 / 16902 (4.4%) | 18728 / 169020 (11.1%) | −192.7 | −190.4 | 0.40 |
| MCM3 SRX9107920 | hTERT RPE-1 Neural | 1017 / 16902 (6.0%) | 3139 / 169020 (1.9%) | −192.3 | −190.1 | 3.24 |
| BCORL1 SRX10184496 | K-562 Blood | 2095 / 16902 (12.4%) | 9986 / 169020 (5.9%) | −191.9 | −189.6 | 2.10 |
| WAS SRX5371250 | GM11518 Blood | 1203 / 16902 (7.1%) | 4196 / 169020 (2.5%) | −191.9 | −189.6 | 2.87 |
| ERG SRX063918 | MCF-7 Breast | 1578 / 16902 (9.3%) | 6511 / 169020 (3.9%) | −191.4 | −189.2 | 2.42 |
| CREBBP SRX359409 | 293 Kidney | 1682 / 16902 (10.0%) | 7197 / 169020 (4.3%) | −190.9 | −188.7 | 2.34 |
| ASCL1 SRX8949802 | Unclassified Unclassified | 1867 / 16902 (11.0%) | 8433 / 169020 (5.0%) | −190.9 | −188.6 | 2.21 |
| KAT6B DRX411444 | 293 Kidney | 2206 / 16902 (13.1%) | 10794 / 169020 (6.4%) | −190.9 | −188.6 | 2.04 |
| JADE3 DRX300415 | 293 Kidney | 1579 / 16902 (9.3%) | 6532 / 169020 (3.9%) | −190.6 | −188.4 | 2.42 |
| TP53 SRX19538280 | Osteoblasts Bone | 340 / 16902 (2.0%) | 257 / 169020 (0.2%) | −190.1 | −187.9 | 13.23 |
| SMARCA4 SRX5212366 | Mel270 Others | 430 / 16902 (2.5%) | 13665 / 169020 (8.1%) | −190.0 | −187.8 | 0.31 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1333 / 16902 (7.9%) | 26673 / 169020 (15.8%) | −189.8 | −187.5 | 0.50 |
| JUN SRX6582172 | Fibroblasts Others | 416 / 16902 (2.5%) | 13420 / 169020 (7.9%) | −189.6 | −187.3 | 0.31 |
| CDK9 SRX20230570 | Ishikawa Uterus | 1782 / 16902 (10.5%) | 7893 / 169020 (4.7%) | −189.3 | −187.1 | 2.26 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 418 / 16902 (2.5%) | 13438 / 169020 (8.0%) | −189.1 | −186.9 | 0.31 |
| KAT6B DRX411443 | 293 Kidney | 2228 / 16902 (13.2%) | 10994 / 169020 (6.5%) | −189.0 | −186.8 | 2.03 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 553 / 16902 (3.3%) | 956 / 169020 (0.6%) | −188.9 | −186.7 | 5.78 |
| SMARCA4 SRX5212362 | Mel270 Others | 569 / 16902 (3.4%) | 15836 / 169020 (9.4%) | −188.8 | −186.6 | 0.36 |
| RBFOX2 SRX4708034 | Hep G2 Liver | 1979 / 16902 (11.7%) | 9250 / 169020 (5.5%) | −188.6 | −186.4 | 2.14 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 642 / 16902 (3.8%) | 16903 / 169020 (10.0%) | −187.5 | −185.3 | 0.38 |
| FOXL2 SRX6957431 | KGN Gonad | 777 / 16902 (4.6%) | 18901 / 169020 (11.2%) | −187.5 | −185.3 | 0.41 |
| YAP1 SRX1038945 | IMR-90 Lung | 215 / 16902 (1.3%) | 9810 / 169020 (5.8%) | −187.2 | −184.9 | 0.22 |
| Epitope tags SRX4892334 | 293 Kidney | 2419 / 16902 (14.3%) | 12425 / 169020 (7.4%) | −187.1 | −184.9 | 1.95 |
| ASCL1 SRX8949803 | Unclassified Unclassified | 1980 / 16902 (11.7%) | 9313 / 169020 (5.5%) | −186.2 | −184.0 | 2.13 |
| DOT1L SRX10606583 | GIST-T1 Digestive tract | 1320 / 16902 (7.8%) | 4984 / 169020 (2.9%) | −186.0 | −183.8 | 2.65 |
| IRF3 SRX11453861 | Hep G2 Liver | 252 / 16902 (1.5%) | 84 / 169020 (0.0%) | −185.8 | −183.6 | 30.00 |
| TP53 SRX19538281 | Osteoblasts Bone | 364 / 16902 (2.2%) | 335 / 169020 (0.2%) | −185.5 | −183.3 | 10.87 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 441 / 16902 (2.6%) | 13687 / 169020 (8.1%) | −185.3 | −183.1 | 0.32 |
| Epitope tags SRX10549777 | K-562 Blood | 2492 / 16902 (14.7%) | 13010 / 169020 (7.7%) | −185.2 | −183.0 | 1.92 |
| GATA3 SRX176864 | MCF-7 Breast | 235 / 16902 (1.4%) | 10129 / 169020 (6.0%) | −185.2 | −183.0 | 0.23 |
| Epitope tags SRX3657345 | 293 Kidney | 2413 / 16902 (14.3%) | 12431 / 169020 (7.4%) | −185.1 | −182.9 | 1.94 |
| CDK9 SRX20230572 | Ishikawa Uterus | 1796 / 16902 (10.6%) | 8078 / 169020 (4.8%) | −184.9 | −182.7 | 2.22 |
| LARP7 SRX1177904 | HCT 116 Digestive tract | 1215 / 16902 (7.2%) | 4369 / 169020 (2.6%) | −184.8 | −182.6 | 2.78 |
| NABP2 SRX9523535 | HT-1080 Bone | 1444 / 16902 (8.5%) | 5773 / 169020 (3.4%) | −184.8 | −182.6 | 2.50 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 219 / 16902 (1.3%) | 9814 / 169020 (5.8%) | −184.8 | −182.6 | 0.22 |
| MEN1 SRX11712604 | K-562 Blood | 1468 / 16902 (8.7%) | 5928 / 169020 (3.5%) | −184.7 | −182.5 | 2.48 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 804 / 16902 (4.8%) | 19188 / 169020 (11.4%) | −184.7 | −182.5 | 0.42 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 935 / 16902 (5.5%) | 2791 / 169020 (1.7%) | −184.4 | −182.3 | 3.35 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 834 / 16902 (4.9%) | 19608 / 169020 (11.6%) | −184.4 | −182.3 | 0.43 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 434 / 16902 (2.6%) | 13547 / 169020 (8.0%) | −184.4 | −182.2 | 0.32 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 251 / 16902 (1.5%) | 10395 / 169020 (6.2%) | −184.3 | −182.1 | 0.24 |
| JUNB SRX4192882 | MCF 10A Breast | 240 / 16902 (1.4%) | 10148 / 169020 (6.0%) | −182.8 | −180.6 | 0.24 |
| TET2 SRX2513053 | Jurkat Blood | 2170 / 16902 (12.8%) | 10735 / 169020 (6.4%) | −182.5 | −180.4 | 2.02 |
| Epitope tags SRX14024875 | Mesenchymal stem cells Others | 1867 / 16902 (11.0%) | 8612 / 169020 (5.1%) | −182.4 | −180.3 | 2.17 |
| TET1 SRX10382426 | hESC H1 Pluripotent stem cell | 2476 / 16902 (14.6%) | 12972 / 169020 (7.7%) | −182.2 | −180.0 | 1.91 |
| G3BP1 SRX24196609 | KGN Gonad | 1693 / 16902 (10.0%) | 7442 / 169020 (4.4%) | −182.1 | −180.0 | 2.27 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 591 / 16902 (3.5%) | 15929 / 169020 (9.4%) | −181.9 | −179.7 | 0.37 |
| RUNX1 SRX2963102 | PBMC Blood | 1999 / 16902 (11.8%) | 9545 / 169020 (5.6%) | −181.7 | −179.6 | 2.09 |
| SUZ12 SRX10184495 | K-562 Blood | 2075 / 16902 (12.3%) | 10088 / 169020 (6.0%) | −181.4 | −179.3 | 2.06 |
| MethylCap SRX014766 | NB-4 Blood | 1635 / 16902 (9.7%) | 7083 / 169020 (4.2%) | −180.8 | −178.6 | 2.31 |
| INTS3 SRX3640569 | HeLa Uterus | 1329 / 16902 (7.9%) | 5124 / 169020 (3.0%) | −180.7 | −178.5 | 2.59 |
| BRD4 SRX23813262 | C4-2B Prostate | 1625 / 16902 (9.6%) | 7020 / 169020 (4.2%) | −180.6 | −178.4 | 2.31 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 860 / 16902 (5.1%) | 2442 / 169020 (1.4%) | −180.4 | −178.3 | 3.52 |
| YAP1 SRX10119364 | MCF 10A Breast | 262 / 16902 (1.6%) | 10472 / 169020 (6.2%) | −180.3 | −178.1 | 0.25 |
| JUN SRX883584 | MDA-MB-231 Breast | 534 / 16902 (3.2%) | 14990 / 169020 (8.9%) | −180.2 | −178.0 | 0.36 |
| FOXA1 SRX1161177 | MCF-7 Breast | 353 / 16902 (2.1%) | 12049 / 169020 (7.1%) | −179.7 | −177.6 | 0.29 |
| TP53 SRX19538269 | U2OS Bone | 398 / 16902 (2.4%) | 458 / 169020 (0.3%) | −179.6 | −177.5 | 8.69 |
| CDK9 SRX20230574 | Ishikawa Uterus | 1555 / 16902 (9.2%) | 6581 / 169020 (3.9%) | −179.5 | −177.4 | 2.36 |
| FOXA1 SRX3931044 | MCF-7 Breast | 756 / 16902 (4.5%) | 18291 / 169020 (10.8%) | −179.3 | −177.1 | 0.41 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 466 / 16902 (2.8%) | 13881 / 169020 (8.2%) | −179.1 | −177.0 | 0.34 |
| JUN SRX2355072 | HAEC Cardiovascular | 441 / 16902 (2.6%) | 13479 / 169020 (8.0%) | −179.0 | −176.9 | 0.33 |
| BRD4 SRX736204 | 90-8TL Neural | 929 / 16902 (5.5%) | 2828 / 169020 (1.7%) | −178.6 | −176.5 | 3.29 |
| AR SRX10820653 | LNCAP Prostate | 308 / 16902 (1.8%) | 214 / 169020 (0.1%) | −178.5 | −176.4 | 14.39 |
| ESR1 SRX371478 | MCF-7 Breast | 464 / 16902 (2.7%) | 13822 / 169020 (8.2%) | −178.3 | −176.1 | 0.34 |
| ING2 SRX286201 | RKO Digestive tract | 1456 / 16902 (8.6%) | 5967 / 169020 (3.5%) | −178.2 | −176.0 | 2.44 |
| TP53 SRX396254 | Fibroblasts Others | 912 / 16902 (5.4%) | 2745 / 169020 (1.6%) | −177.9 | −175.8 | 3.32 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 296 / 16902 (1.8%) | 11000 / 169020 (6.5%) | −177.7 | −175.6 | 0.27 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 361 / 16902 (2.1%) | 12116 / 169020 (7.2%) | −177.6 | −175.5 | 0.30 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 299 / 16902 (1.8%) | 11049 / 169020 (6.5%) | −177.5 | −175.4 | 0.27 |
| DDX21 SRX8257415 | A-375 Epidermis | 995 / 16902 (5.9%) | 3213 / 169020 (1.9%) | −176.8 | −174.6 | 3.10 |
| KDM5B SRX3285614 | C70R Breast | 1535 / 16902 (9.1%) | 6510 / 169020 (3.9%) | −176.3 | −174.2 | 2.36 |
| ESR1 SRX2901942 | Ishikawa Uterus | 1229 / 16902 (7.3%) | 4581 / 169020 (2.7%) | −176.3 | −174.2 | 2.68 |
| JUNB SRX10119386 | MCF 10A Breast | 293 / 16902 (1.7%) | 10895 / 169020 (6.4%) | −176.1 | −173.9 | 0.27 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 670 / 16902 (4.0%) | 16895 / 169020 (10.0%) | −175.7 | −173.6 | 0.40 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 446 / 16902 (2.6%) | 13440 / 169020 (8.0%) | −175.5 | −173.3 | 0.33 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 448 / 16902 (2.7%) | 13453 / 169020 (8.0%) | −174.9 | −172.8 | 0.33 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 314 / 16902 (1.9%) | 11220 / 169020 (6.6%) | −174.7 | −172.6 | 0.28 |
| SMARCA4 SRX5212371 | Mel270 Others | 484 / 16902 (2.9%) | 14014 / 169020 (8.3%) | −174.6 | −172.5 | 0.35 |
| PCGF1 SRX3256864 | hESC H1 Pluripotent stem cell | 2198 / 16902 (13.0%) | 11136 / 169020 (6.6%) | −174.6 | −172.5 | 1.97 |
| GATA3 SRX5057632 | MCF-7 Breast | 213 / 16902 (1.3%) | 9399 / 169020 (5.6%) | −174.6 | −172.4 | 0.23 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 509 / 16902 (3.0%) | 14403 / 169020 (8.5%) | −174.5 | −172.4 | 0.35 |
| SMARCA4 SRX5212357 | Mel270 Others | 499 / 16902 (3.0%) | 14244 / 169020 (8.4%) | −174.5 | −172.4 | 0.35 |
| KLF4 SRX12144701 | T/C28a2 Bone | 2750 / 16902 (16.3%) | 15259 / 169020 (9.0%) | −174.3 | −172.2 | 1.80 |
| KMT2A SRX8151119 | VDH-15 Others | 1951 / 16902 (11.5%) | 9387 / 169020 (5.6%) | −174.0 | −171.9 | 2.08 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1113 / 16902 (6.6%) | 3927 / 169020 (2.3%) | −173.8 | −171.7 | 2.83 |
| KDM5B SRX3285611 | MCF-7 Breast | 1297 / 16902 (7.7%) | 5043 / 169020 (3.0%) | −173.6 | −171.5 | 2.57 |
| Epitope tags SRX8030771 | 293 Kidney | 1661 / 16902 (9.8%) | 7409 / 169020 (4.4%) | −173.1 | −171.0 | 2.24 |
| FOS SRX4192879 | MCF 10A Breast | 398 / 16902 (2.4%) | 12574 / 169020 (7.4%) | −173.0 | −170.9 | 0.32 |
| NR3C1 SRX2609659 | HASM2 Lung | 394 / 16902 (2.3%) | 12505 / 169020 (7.4%) | −172.9 | −170.8 | 0.32 |
| ZNF711 SRX7805362 | 293 Kidney | 1499 / 16902 (8.9%) | 6347 / 169020 (3.8%) | −172.7 | −170.6 | 2.36 |
| ESR1 SRX2897217 | Breast cancer cells Breast | 1022 / 16902 (6.0%) | 3423 / 169020 (2.0%) | −172.3 | −170.2 | 2.99 |
| GTF3C1 SRX4636577 | 293 Kidney | 1369 / 16902 (8.1%) | 5526 / 169020 (3.3%) | −171.8 | −169.7 | 2.48 |
| AFF1 SRX2281250 | SEM Blood | 1017 / 16902 (6.0%) | 3401 / 169020 (2.0%) | −171.7 | −169.6 | 2.99 |
| SSRP1 SRX3436567 | HT-1080 Bone | 417 / 16902 (2.5%) | 558 / 169020 (0.3%) | −171.4 | −169.3 | 7.47 |
| KMT2A SRX8151120 | VDH-15 Others | 2098 / 16902 (12.4%) | 10499 / 169020 (6.2%) | −171.2 | −169.1 | 2.00 |
| KMT2A SRX8151117 | VDH-15 Others | 2111 / 16902 (12.5%) | 10598 / 169020 (6.3%) | −171.0 | −168.9 | 1.99 |
| KMT2A SRX8151118 | VDH-15 Others | 2035 / 16902 (12.0%) | 10078 / 169020 (6.0%) | −169.9 | −167.9 | 2.02 |
| FOXA1 SRX371482 | MCF-7 Breast | 536 / 16902 (3.2%) | 14661 / 169020 (8.7%) | −169.9 | −167.8 | 0.37 |
| KMT2A SRX8151116 | VDH-15 Others | 1719 / 16902 (10.2%) | 7886 / 169020 (4.7%) | −169.2 | −167.1 | 2.18 |
| LARP7 SRX2198835 | HeLa Uterus | 2120 / 16902 (12.5%) | 10707 / 169020 (6.3%) | −169.2 | −167.1 | 1.98 |
| NR3C1 SRX2609664 | HASM2 Lung | 494 / 16902 (2.9%) | 13983 / 169020 (8.3%) | −169.2 | −167.1 | 0.35 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 683 / 16902 (4.0%) | 16837 / 169020 (10.0%) | −169.0 | −167.0 | 0.41 |
| CEBPB SRX150632 | HeLa Uterus | 805 / 16902 (4.8%) | 18595 / 169020 (11.0%) | −168.8 | −166.8 | 0.43 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 613 / 16902 (3.6%) | 15783 / 169020 (9.3%) | −168.6 | −166.6 | 0.39 |
| ZNF711 SRX7805363 | 293 Kidney | 1556 / 16902 (9.2%) | 6801 / 169020 (4.0%) | −168.5 | −166.4 | 2.29 |
| JUN SRX7277180 | GM07492 Others | 268 / 16902 (1.6%) | 10215 / 169020 (6.0%) | −168.5 | −166.4 | 0.26 |
| ARID1A SRX5679787 | 12Z Others | 105 / 16902 (0.6%) | 7036 / 169020 (4.2%) | −168.2 | −166.1 | 0.15 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 506 / 16902 (3.0%) | 14132 / 169020 (8.4%) | −168.1 | −166.1 | 0.36 |
| FOS SRX070879 | HUVEC Cardiovascular | 360 / 16902 (2.1%) | 11774 / 169020 (7.0%) | −167.8 | −165.7 | 0.31 |
| GATA3 SRX190239 | MCF-7 Breast | 541 / 16902 (3.2%) | 14647 / 169020 (8.7%) | −167.4 | −165.4 | 0.37 |
| NR1D1 SRX23813275 | C4-2B Prostate | 1769 / 16902 (10.5%) | 8268 / 169020 (4.9%) | −167.3 | −165.2 | 2.14 |
| ZBTB26 SRX3322067 | 293 Kidney | 1925 / 16902 (11.4%) | 9363 / 169020 (5.5%) | −167.2 | −165.1 | 2.06 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 443 / 16902 (2.6%) | 13102 / 169020 (7.8%) | −167.1 | −165.0 | 0.34 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 763 / 16902 (4.5%) | 2089 / 169020 (1.2%) | −167.0 | −164.9 | 3.65 |
| ESR1 SRX371476 | MCF-7 Breast | 267 / 16902 (1.6%) | 10139 / 169020 (6.0%) | −166.6 | −164.5 | 0.26 |
| SP1 SRX113706 | HCT 116 Digestive tract | 1845 / 16902 (10.9%) | 8819 / 169020 (5.2%) | −166.3 | −164.2 | 2.09 |
| HDAC1 SRX20517422 | Keratinocytes Epidermis | 1393 / 16902 (8.2%) | 5785 / 169020 (3.4%) | −165.9 | −163.9 | 2.41 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 321 / 16902 (1.9%) | 11055 / 169020 (6.5%) | −165.9 | −163.8 | 0.29 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 624 / 16902 (3.7%) | 1431 / 169020 (0.8%) | −165.5 | −163.5 | 4.36 |
| RBFOX2 SRX4708082 | K-562 Blood | 2346 / 16902 (13.9%) | 12468 / 169020 (7.4%) | −165.3 | −163.2 | 1.88 |
| CDT1 SRX10644243 | HCT 116 Digestive tract | 1641 / 16902 (9.7%) | 7441 / 169020 (4.4%) | −165.1 | −163.1 | 2.21 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 617 / 16902 (3.7%) | 15708 / 169020 (9.3%) | −164.9 | −162.9 | 0.39 |
| TEAD1 SRX716558 | SF268 Neural | 153 / 16902 (0.9%) | 7931 / 169020 (4.7%) | −164.3 | −162.3 | 0.19 |
| MBD3 SRX1674506 | HeLa Uterus | 2603 / 16902 (15.4%) | 14433 / 169020 (8.5%) | −164.3 | −162.2 | 1.80 |
| EP300 SRX2194265 | SUM 159PT Breast | 566 / 16902 (3.3%) | 14901 / 169020 (8.8%) | −163.8 | −161.8 | 0.38 |
| NKX2-1 SRX2164786 | A549 Lung | 598 / 16902 (3.5%) | 15378 / 169020 (9.1%) | −163.7 | −161.6 | 0.39 |
| ASCL1 SRX11245139 | DMS 53 Lung | 1496 / 16902 (8.9%) | 6502 / 169020 (3.8%) | −163.6 | −161.6 | 2.30 |
| Epitope tags SRX7276675 | 293 Kidney | 2412 / 16902 (14.3%) | 13008 / 169020 (7.7%) | −163.6 | −161.6 | 1.85 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 779 / 16902 (4.6%) | 2208 / 169020 (1.3%) | −163.5 | −161.5 | 3.53 |
| ERG SRX063917 | MCF-7 Breast | 1463 / 16902 (8.7%) | 6286 / 169020 (3.7%) | −163.5 | −161.4 | 2.33 |
| PGR SRX6068069 | Endometrium Uterus | 1834 / 16902 (10.9%) | 8809 / 169020 (5.2%) | −163.4 | −161.3 | 2.08 |
| FOXL2 SRX6957477 | KGN Gonad | 363 / 16902 (2.1%) | 11676 / 169020 (6.9%) | −163.3 | −161.3 | 0.31 |
| ARID1A SRX5679788 | 12Z Others | 125 / 16902 (0.7%) | 7317 / 169020 (4.3%) | −162.8 | −160.8 | 0.17 |
| KDM4C SRX424010 | KYSE-150 Digestive tract | 1244 / 16902 (7.4%) | 4896 / 169020 (2.9%) | −162.8 | −160.8 | 2.54 |
| HDAC1 SRX17989501 | PBMC Blood | 2058 / 16902 (12.2%) | 10424 / 169020 (6.2%) | −162.6 | −160.6 | 1.97 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 808 / 16902 (4.8%) | 18387 / 169020 (10.9%) | −162.4 | −160.4 | 0.44 |
| JUN SRX4192884 | MCF 10A Breast | 291 / 16902 (1.7%) | 10429 / 169020 (6.2%) | −162.4 | −160.4 | 0.28 |
| EP300 SRX2194266 | SUM 159PT Breast | 632 / 16902 (3.7%) | 15834 / 169020 (9.4%) | −162.4 | −160.3 | 0.40 |
| FOXA1 SRX1161173 | MCF-7 Breast | 296 / 16902 (1.8%) | 10512 / 169020 (6.2%) | −162.3 | −160.3 | 0.28 |
| ESR1 SRX371469 | MCF-7 Breast | 405 / 16902 (2.4%) | 12321 / 169020 (7.3%) | −162.0 | −160.0 | 0.33 |
| FOXA1 SRX1161175 | MCF-7 Breast | 277 / 16902 (1.6%) | 10173 / 169020 (6.0%) | −162.0 | −160.0 | 0.27 |
| KMT2A SRX2281247 | SEM Blood | 1634 / 16902 (9.7%) | 7479 / 169020 (4.4%) | −161.1 | −159.1 | 2.18 |
| ESR1 SRX371479 | MCF-7 Breast | 361 / 16902 (2.1%) | 11568 / 169020 (6.8%) | −161.0 | −159.0 | 0.31 |
| TFAP2A SRX20744801 | GP5d Digestive tract | 1011 / 16902 (6.0%) | 3518 / 169020 (2.1%) | −161.0 | −159.0 | 2.87 |
| WAS SRX5371248 | Lymphoblastoid cell line Blood | 965 / 16902 (5.7%) | 3255 / 169020 (1.9%) | −160.8 | −158.8 | 2.96 |
| MAU2 SRX15710550 | Fibroblasts Others | 600 / 16902 (3.5%) | 15302 / 169020 (9.1%) | −160.8 | −158.8 | 0.39 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 243 / 16902 (1.4%) | 118 / 169020 (0.1%) | −160.8 | −158.8 | 20.59 |
| JUN SRX6582163 | BJ-5ta Epidermis | 452 / 16902 (2.7%) | 13027 / 169020 (7.7%) | −160.7 | −158.7 | 0.35 |
| Epitope tags SRX15683099 | HS-SY-II Lung | 1967 / 16902 (11.6%) | 9815 / 169020 (5.8%) | −160.7 | −158.7 | 2.00 |
| RBFOX2 SRX3323050 | Hep G2 Liver | 1552 / 16902 (9.2%) | 6955 / 169020 (4.1%) | −159.5 | −157.5 | 2.23 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1513 / 16902 (9.0%) | 6697 / 169020 (4.0%) | −159.5 | −157.5 | 2.26 |
| Epitope tags SRX22482468 | 293 Kidney | 1334 / 16902 (7.9%) | 5523 / 169020 (3.3%) | −159.4 | −157.4 | 2.42 |
| KDM2B SRX3256862 | hESC H1 Pluripotent stem cell | 2453 / 16902 (14.5%) | 13434 / 169020 (7.9%) | −159.4 | −157.4 | 1.83 |
| STAT1 SRX23678708 | K-562 Blood | 1513 / 16902 (9.0%) | 6702 / 169020 (4.0%) | −159.2 | −157.2 | 2.26 |
| TAF1 SRX11120885 | MCF-7 Breast | 1687 / 16902 (10.0%) | 7889 / 169020 (4.7%) | −159.0 | −157.0 | 2.14 |
| FOXA1 SRX1161176 | MCF-7 Breast | 368 / 16902 (2.2%) | 11613 / 169020 (6.9%) | −158.9 | −156.9 | 0.32 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 395 / 16902 (2.3%) | 12048 / 169020 (7.1%) | −158.8 | −156.8 | 0.33 |
| DMC1 SRX663450 | Testis Gonad | 619 / 16902 (3.7%) | 1471 / 169020 (0.9%) | −158.3 | −156.3 | 4.21 |
| ASCL1 SRX8949797 | Unclassified Unclassified | 2051 / 16902 (12.1%) | 10486 / 169020 (6.2%) | −158.2 | −156.2 | 1.96 |
| STAT5B SRX831881 | CD8+ T cells Blood | 253 / 16902 (1.5%) | 145 / 169020 (0.1%) | −158.1 | −156.1 | 17.45 |
| RTF1 SRX15147196 | DLD-1 Digestive tract | 701 / 16902 (4.1%) | 1870 / 169020 (1.1%) | −158.0 | −156.0 | 3.75 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 302 / 16902 (1.8%) | 10472 / 169020 (6.2%) | −157.9 | −155.9 | 0.29 |
| CTCF SRX12008354 | MCF 10A Breast | 3859 / 16902 (22.8%) | 24727 / 169020 (14.6%) | −157.5 | −155.6 | 1.56 |
| FOXA1 SRX371483 | MCF-7 Breast | 443 / 16902 (2.6%) | 12771 / 169020 (7.6%) | −157.5 | −155.5 | 0.35 |
| EP300 SRX150579 | HeLa Uterus | 228 / 16902 (1.3%) | 9151 / 169020 (5.4%) | −157.3 | −155.3 | 0.25 |
| NR3C1 SRX2609665 | HASM2 Lung | 404 / 16902 (2.4%) | 12133 / 169020 (7.2%) | −157.0 | −155.0 | 0.33 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1074 / 16902 (6.4%) | 21835 / 169020 (12.9%) | −157.0 | −155.0 | 0.49 |
| CEBPB SRX150598 | IMR-90 Lung | 758 / 16902 (4.5%) | 17463 / 169020 (10.3%) | −157.0 | −155.0 | 0.43 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 672 / 16902 (4.0%) | 16216 / 169020 (9.6%) | −156.9 | −154.9 | 0.41 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 655 / 16902 (3.9%) | 15961 / 169020 (9.4%) | −156.7 | −154.7 | 0.41 |
| AR SRX10820651 | LNCAP Prostate | 323 / 16902 (1.9%) | 327 / 169020 (0.2%) | −156.7 | −154.7 | 9.88 |
| VGLL1 SRX24602130 | BT-20 Breast | 381 / 16902 (2.3%) | 11747 / 169020 (7.0%) | −156.6 | −154.6 | 0.32 |
| KDM5B SRX3285565 | C70R Breast | 1116 / 16902 (6.6%) | 4213 / 169020 (2.5%) | −156.3 | −154.3 | 2.65 |
| STAT5A SRX9681372 | ARP-1 Blood | 1380 / 16902 (8.2%) | 5894 / 169020 (3.5%) | −155.7 | −153.7 | 2.34 |
| KAT6A DRX411442 | 293 Kidney | 1692 / 16902 (10.0%) | 8001 / 169020 (4.7%) | −155.5 | −153.5 | 2.11 |
| TET1 SRX10382404 | hESC H1 Pluripotent stem cell | 2367 / 16902 (14.0%) | 12908 / 169020 (7.6%) | −155.2 | −153.3 | 1.83 |
| NR3C1 SRX2609666 | HASM2 Lung | 349 / 16902 (2.1%) | 11174 / 169020 (6.6%) | −155.2 | −153.2 | 0.31 |
| ZFX SRX7805365 | 22Rv1 Prostate | 1353 / 16902 (8.0%) | 5727 / 169020 (3.4%) | −155.2 | −153.2 | 2.36 |
| FOS SRX150664 | HUVEC Cardiovascular | 488 / 16902 (2.9%) | 13395 / 169020 (7.9%) | −155.1 | −153.2 | 0.36 |
| NR3C1 SRX2609661 | HASM2 Lung | 408 / 16902 (2.4%) | 12133 / 169020 (7.2%) | −155.1 | −153.1 | 0.34 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 467 / 16902 (2.8%) | 13066 / 169020 (7.7%) | −155.1 | −153.1 | 0.36 |
| KDM5A SRX23740431 | SUM 149PT Breast | 1463 / 16902 (8.7%) | 6455 / 169020 (3.8%) | −155.0 | −153.1 | 2.27 |
| BCOR SRX3256873 | hESC H1 Pluripotent stem cell | 2266 / 16902 (13.4%) | 12162 / 169020 (7.2%) | −154.7 | −152.8 | 1.86 |
| BAHCC1 SRX8449942 | Jurkat Blood | 2508 / 16902 (14.8%) | 13991 / 169020 (8.3%) | −154.7 | −152.8 | 1.79 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 836 / 16902 (4.9%) | 2614 / 169020 (1.5%) | −154.7 | −152.8 | 3.20 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 690 / 16902 (4.1%) | 16393 / 169020 (9.7%) | −154.6 | −152.6 | 0.42 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 495 / 16902 (2.9%) | 13469 / 169020 (8.0%) | −154.3 | −152.3 | 0.37 |
| FOSL2 SRX190204 | A549 Lung | 362 / 16902 (2.1%) | 11351 / 169020 (6.7%) | −154.1 | −152.2 | 0.32 |
| BRD4 SRX2166889 | Retina Neural | 1396 / 16902 (8.3%) | 6037 / 169020 (3.6%) | −153.7 | −151.8 | 2.31 |
| Epitope tags SRX25968097 | Brain organoids Neural | 1411 / 16902 (8.3%) | 6140 / 169020 (3.6%) | −153.5 | −151.5 | 2.30 |
| ERG SRX026657 | Acute promyelocytic leukemia Blood | 1870 / 16902 (11.1%) | 9305 / 169020 (5.5%) | −153.4 | −151.4 | 2.01 |
| KAT7 DRX234808 | 293 Kidney | 776 / 16902 (4.6%) | 2308 / 169020 (1.4%) | −153.3 | −151.3 | 3.36 |
| HDAC1 SRX20419390 | Keratinocytes Epidermis | 1196 / 16902 (7.1%) | 4758 / 169020 (2.8%) | −153.2 | −151.3 | 2.51 |
| FOXA1 SRX371481 | MCF-7 Breast | 427 / 16902 (2.5%) | 12346 / 169020 (7.3%) | −152.5 | −150.6 | 0.35 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 579 / 16902 (3.4%) | 14677 / 169020 (8.7%) | −152.5 | −150.5 | 0.39 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 260 / 16902 (1.5%) | 9571 / 169020 (5.7%) | −152.4 | −150.5 | 0.27 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 634 / 16902 (3.8%) | 15487 / 169020 (9.2%) | −152.3 | −150.4 | 0.41 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 563 / 16902 (3.3%) | 14426 / 169020 (8.5%) | −152.0 | −150.1 | 0.39 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 361 / 16902 (2.1%) | 11268 / 169020 (6.7%) | −152.0 | −150.1 | 0.32 |
| JUNB SRX10119383 | MCF 10A Breast | 246 / 16902 (1.5%) | 9310 / 169020 (5.5%) | −152.0 | −150.0 | 0.26 |
| DAXX SRX1021630 | PC-3 Prostate | 378 / 16902 (2.2%) | 11542 / 169020 (6.8%) | −151.9 | −150.0 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 183 / 16902 (1.1%) | 8145 / 169020 (4.8%) | −151.7 | −149.7 | 0.22 |
| YAP1 SRX1038944 | IMR-90 Lung | 123 / 16902 (0.7%) | 6950 / 169020 (4.1%) | −151.4 | −149.5 | 0.18 |
| TP53 SRX19538270 | U2OS Bone | 359 / 16902 (2.1%) | 462 / 169020 (0.3%) | −151.3 | −149.4 | 7.77 |
| NR3C1 SRX2609662 | HASM2 Lung | 453 / 16902 (2.7%) | 12709 / 169020 (7.5%) | −151.1 | −149.2 | 0.36 |
| SMARCA4 SRX9562887 | RH-4 Muscle | 1476 / 16902 (8.7%) | 6625 / 169020 (3.9%) | −151.0 | −149.0 | 2.23 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 332 / 16902 (2.0%) | 10751 / 169020 (6.4%) | −150.9 | −149.0 | 0.31 |
| CTCF SRX10976001 | NALM-6 Blood | 2482 / 16902 (14.7%) | 13911 / 169020 (8.2%) | −150.9 | −149.0 | 1.78 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 381 / 16902 (2.3%) | 11546 / 169020 (6.8%) | −150.7 | −148.7 | 0.33 |
| KLF4 SRX12144702 | T/C28a2 Bone | 2414 / 16902 (14.3%) | 13398 / 169020 (7.9%) | −150.6 | −148.7 | 1.80 |
| EP300 SRX24299743 | hESC H9 Pluripotent stem cell | 1632 / 16902 (9.7%) | 7696 / 169020 (4.6%) | −150.6 | −148.6 | 2.12 |
| FOXA1 SRX371480 | MCF-7 Breast | 269 / 16902 (1.6%) | 9665 / 169020 (5.7%) | −150.4 | −148.5 | 0.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 469 / 16902 (2.8%) | 12926 / 169020 (7.6%) | −150.3 | −148.3 | 0.36 |
| CHD6 SRX17709202 | C4-2 Prostate | 1103 / 16902 (6.5%) | 4233 / 169020 (2.5%) | −150.2 | −148.2 | 2.61 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 254 / 16902 (1.5%) | 9381 / 169020 (5.6%) | −149.8 | −147.9 | 0.27 |
| KDM5B SRX3285604 | FULR Breast | 1389 / 16902 (8.2%) | 6075 / 169020 (3.6%) | −149.5 | −147.6 | 2.29 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1191 / 16902 (7.0%) | 4795 / 169020 (2.8%) | −149.4 | −147.5 | 2.48 |
| KDM5A SRX23740438 | SUM 149PT Breast | 1672 / 16902 (9.9%) | 8002 / 169020 (4.7%) | −149.4 | −147.5 | 2.09 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 670 / 16902 (4.0%) | 15904 / 169020 (9.4%) | −149.4 | −147.5 | 0.42 |
| EP300 SRX100540 | SK-N-SH Neural | 555 / 16902 (3.3%) | 14201 / 169020 (8.4%) | −149.3 | −147.4 | 0.39 |
| JUND SRX699738 | HCASMC Cardiovascular | 529 / 16902 (3.1%) | 13802 / 169020 (8.2%) | −149.1 | −147.2 | 0.38 |
| FOXA1 SRX11222441 | MCF-7 Breast | 297 / 16902 (1.8%) | 10101 / 169020 (6.0%) | −149.1 | −147.2 | 0.29 |
| JUNB SRX8488088 | SUM 229PE Breast | 746 / 16902 (4.4%) | 16967 / 169020 (10.0%) | −148.7 | −146.8 | 0.44 |
| ESR1 SRX194572 | MCF-7 Breast | 253 / 16902 (1.5%) | 9329 / 169020 (5.5%) | −148.7 | −146.8 | 0.27 |
| TLE3 SRX4815191 | MCF-7 Breast | 388 / 16902 (2.3%) | 11590 / 169020 (6.9%) | −148.7 | −146.8 | 0.33 |
| NCAPH2 SRX2731517 | 293 Kidney | 1311 / 16902 (7.8%) | 5580 / 169020 (3.3%) | −148.5 | −146.6 | 2.35 |
| ESR1 SRX371468 | MCF-7 Breast | 256 / 16902 (1.5%) | 9374 / 169020 (5.5%) | −148.4 | −146.5 | 0.27 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 568 / 16902 (3.4%) | 14359 / 169020 (8.5%) | −148.3 | −146.4 | 0.40 |
| HDAC1 SRX17989500 | PBMC Blood | 1552 / 16902 (9.2%) | 7206 / 169020 (4.3%) | −147.9 | −146.0 | 2.15 |
| GTF3C1 SRX4636578 | 293 Kidney | 1310 / 16902 (7.8%) | 5590 / 169020 (3.3%) | −147.7 | −145.8 | 2.34 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 862 / 16902 (5.1%) | 2846 / 169020 (1.7%) | −147.7 | −145.8 | 3.03 |
| EP300 SRX24299742 | hESC H9 Pluripotent stem cell | 1683 / 16902 (10.0%) | 8119 / 169020 (4.8%) | −147.7 | −145.8 | 2.07 |
| KMT2A SRX8151121 | VDH-15 Others | 2070 / 16902 (12.2%) | 10906 / 169020 (6.5%) | −147.6 | −145.7 | 1.90 |
| RBFOX2 SRX3323051 | Hep G2 Liver | 1476 / 16902 (8.7%) | 6698 / 169020 (4.0%) | −147.5 | −145.6 | 2.20 |
| CEBPB SRX2194250 | SUM 159PT Breast | 460 / 16902 (2.7%) | 12684 / 169020 (7.5%) | −147.4 | −145.5 | 0.36 |
| MCM2 SRX12221306 | HCT 116 Digestive tract | 1286 / 16902 (7.6%) | 5444 / 169020 (3.2%) | −147.2 | −145.3 | 2.36 |
| FOXA1 SRX3923514 | MCF-7 Breast | 400 / 16902 (2.4%) | 11723 / 169020 (6.9%) | −146.9 | −145.0 | 0.34 |
| JUND SRX150408 | HeLa Uterus | 336 / 16902 (2.0%) | 10683 / 169020 (6.3%) | −146.9 | −145.0 | 0.31 |
| JUNB SRX10119384 | MCF 10A Breast | 223 / 16902 (1.3%) | 8731 / 169020 (5.2%) | −146.7 | −144.8 | 0.26 |
| CTCF SRX10976007 | NALM-6 Blood | 2498 / 16902 (14.8%) | 14171 / 169020 (8.4%) | −146.5 | −144.6 | 1.76 |
| Epitope tags SRX8109065 | Gastric cancer cells Digestive tract | 1623 / 16902 (9.6%) | 7729 / 169020 (4.6%) | −146.4 | −144.5 | 2.10 |
| FOXA1 SRX11222442 | MCF-7 Breast | 257 / 16902 (1.5%) | 9321 / 169020 (5.5%) | −146.2 | −144.3 | 0.28 |
| KDM5B SRX3285563 | C49R Breast | 1322 / 16902 (7.8%) | 5699 / 169020 (3.4%) | −146.1 | −144.2 | 2.32 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 472 / 16902 (2.8%) | 12817 / 169020 (7.6%) | −145.9 | −144.0 | 0.37 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 236 / 16902 (1.4%) | 8921 / 169020 (5.3%) | −145.3 | −143.4 | 0.26 |
| HDAC2 SRX16386913 | 293 Kidney | 784 / 16902 (4.6%) | 2447 / 169020 (1.4%) | −145.3 | −143.4 | 3.20 |
| KDM4A SRX5266973 | THP-1 Blood | 1807 / 16902 (10.7%) | 9054 / 169020 (5.4%) | −145.2 | −143.3 | 2.00 |
| CREBBP SRX359408 | 293 Kidney | 1301 / 16902 (7.7%) | 5580 / 169020 (3.3%) | −145.1 | −143.3 | 2.33 |
| JUN SRX6582164 | BJ-5ta Epidermis | 485 / 16902 (2.9%) | 12968 / 169020 (7.7%) | −144.6 | −142.7 | 0.37 |
| JADE3 DRX234809 | 293 Kidney | 990 / 16902 (5.9%) | 3638 / 169020 (2.2%) | −144.5 | −142.6 | 2.72 |
| GFP SRX17864030 | 293 Kidney | 1442 / 16902 (8.5%) | 6535 / 169020 (3.9%) | −144.3 | −142.4 | 2.21 |
| BCOR SRX10184505 | KG-1 Blood | 937 / 16902 (5.5%) | 3330 / 169020 (2.0%) | −144.2 | −142.3 | 2.81 |
| FOXA1 SRX100506 | Hep G2 Liver | 520 / 16902 (3.1%) | 13479 / 169020 (8.0%) | −144.1 | −142.2 | 0.39 |
| JUN SRX150358 | HUVEC Cardiovascular | 243 / 16902 (1.4%) | 8998 / 169020 (5.3%) | −143.8 | −141.9 | 0.27 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 598 / 16902 (3.5%) | 14627 / 169020 (8.7%) | −143.7 | −141.8 | 0.41 |
| AR SRX1067071 | LHSAR Prostate | 782 / 16902 (4.6%) | 17262 / 169020 (10.2%) | −143.4 | −141.5 | 0.45 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 377 / 16902 (2.2%) | 11228 / 169020 (6.6%) | −143.3 | −141.4 | 0.34 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 312 / 16902 (1.8%) | 10165 / 169020 (6.0%) | −143.3 | −141.4 | 0.31 |
| FOS SRX3322636 | MCF-7 Breast | 253 / 16902 (1.5%) | 9154 / 169020 (5.4%) | −143.2 | −141.3 | 0.28 |
| SUZ12 SRX9281791 | 293 Kidney | 382 / 16902 (2.3%) | 584 / 169020 (0.3%) | −143.2 | −141.3 | 6.54 |
| KMT2B DRX059614 | HB1119 Blood | 866 / 16902 (5.1%) | 2933 / 169020 (1.7%) | −143.2 | −141.3 | 2.95 |
| MED1 SRX5236337 | HUVEC Cardiovascular | 570 / 16902 (3.4%) | 1378 / 169020 (0.8%) | −143.0 | −141.2 | 4.14 |
| EP300 SRX190219 | SK-N-SH Neural | 378 / 16902 (2.2%) | 11236 / 169020 (6.6%) | −143.0 | −141.2 | 0.34 |
| TRIM24 SRX1041842 | LNCAP Prostate | 1117 / 16902 (6.6%) | 4455 / 169020 (2.6%) | −142.3 | −140.4 | 2.51 |
| TP53 SRX19538282 | Osteoblasts Bone | 310 / 16902 (1.8%) | 348 / 169020 (0.2%) | −142.0 | −140.1 | 8.91 |
| WWTR1 SRX10119367 | MCF 10A Breast | 464 / 16902 (2.7%) | 12541 / 169020 (7.4%) | −141.8 | −139.9 | 0.37 |
| PBRM1 SRX25399433 | Melanoma Epidermis | 1127 / 16902 (6.7%) | 4526 / 169020 (2.7%) | −141.8 | −139.9 | 2.49 |
| JUN SRX2355073 | HAEC Cardiovascular | 489 / 16902 (2.9%) | 12926 / 169020 (7.6%) | −141.7 | −139.9 | 0.38 |
| FOXA2 SRX3230382 | Hep G2 Liver | 540 / 16902 (3.2%) | 13694 / 169020 (8.1%) | −141.6 | −139.8 | 0.39 |
| TRIM25 SRX1660871 | Breast cancer cells Breast | 1510 / 16902 (8.9%) | 7060 / 169020 (4.2%) | −141.4 | −139.6 | 2.14 |
| BRD4 SRX23813261 | C4-2B Prostate | 1269 / 16902 (7.5%) | 5445 / 169020 (3.2%) | −141.4 | −139.5 | 2.33 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 379 / 16902 (2.2%) | 11192 / 169020 (6.6%) | −141.3 | −139.4 | 0.34 |
| ATF1 SRX11470442 | Mesenchymal stem cells Others | 499 / 16902 (3.0%) | 13054 / 169020 (7.7%) | −141.1 | −139.2 | 0.38 |
| ESR1 SRX371471 | ZR-75-1 Breast | 461 / 16902 (2.7%) | 12469 / 169020 (7.4%) | −141.0 | −139.1 | 0.37 |
| NIPBL SRX7805899 | Dermal fibroblast Epidermis | 1175 / 16902 (7.0%) | 4848 / 169020 (2.9%) | −140.8 | −138.9 | 2.42 |
| FOXA1 SRX11222437 | MCF-7 Breast | 289 / 16902 (1.7%) | 9690 / 169020 (5.7%) | −140.7 | −138.8 | 0.30 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 305 / 16902 (1.8%) | 9954 / 169020 (5.9%) | −140.5 | −138.7 | 0.31 |
| FOXA1 SRX1787653 | MCF-7 Breast | 335 / 16902 (2.0%) | 10447 / 169020 (6.2%) | −140.5 | −138.6 | 0.32 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 266 / 16902 (1.6%) | 9278 / 169020 (5.5%) | −140.1 | −138.2 | 0.29 |
| BCOR SRX10184504 | OCI-AML3 Blood | 1551 / 16902 (9.2%) | 7377 / 169020 (4.4%) | −140.0 | −138.2 | 2.10 |
| RBM22 SRX4708083 | K-562 Blood | 893 / 16902 (5.3%) | 3141 / 169020 (1.9%) | −139.5 | −137.6 | 2.84 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 568 / 16902 (3.4%) | 14021 / 169020 (8.3%) | −139.4 | −137.5 | 0.41 |
| BCOR SRX3256874 | hESC H1 Pluripotent stem cell | 1945 / 16902 (11.5%) | 10215 / 169020 (6.0%) | −139.2 | −137.3 | 1.90 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 297 / 16902 (1.8%) | 9755 / 169020 (5.8%) | −138.5 | −136.6 | 0.30 |
| ESR1 SRX371470 | ZR-75-1 Breast | 397 / 16902 (2.3%) | 11376 / 169020 (6.7%) | −138.3 | −136.5 | 0.35 |
| Epitope tags SRX5770333 | HCT 116 Digestive tract | 1234 / 16902 (7.3%) | 5274 / 169020 (3.1%) | −138.3 | −136.4 | 2.34 |
| ZBTB26 SRX3322068 | 293 Kidney | 1735 / 16902 (10.3%) | 8715 / 169020 (5.2%) | −138.2 | −136.4 | 1.99 |
| NR3C1 SRX10976921 | A549 Lung | 274 / 16902 (1.6%) | 9349 / 169020 (5.5%) | −138.1 | −136.2 | 0.29 |
| BCOR SRX10184500 | Acute myeloid leukemia Blood | 1570 / 16902 (9.3%) | 7554 / 169020 (4.5%) | −138.1 | −136.2 | 2.08 |
| RELA SRX7055007 | HAEC Cardiovascular | 721 / 16902 (4.3%) | 16186 / 169020 (9.6%) | −138.1 | −136.2 | 0.45 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 290 / 16902 (1.7%) | 9617 / 169020 (5.7%) | −138.0 | −136.2 | 0.30 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 347 / 16902 (2.1%) | 10558 / 169020 (6.2%) | −137.9 | −136.1 | 0.33 |
| STAT1 SRX23678707 | K-562 Blood | 1361 / 16902 (8.1%) | 6125 / 169020 (3.6%) | −137.9 | −136.1 | 2.22 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 377 / 16902 (2.2%) | 11034 / 169020 (6.5%) | −137.8 | −135.9 | 0.34 |
| BRD4 SRX2166886 | Retina Neural | 1703 / 16902 (10.1%) | 8510 / 169020 (5.0%) | −137.3 | −135.5 | 2.00 |
| FOXA1 SRX5323843 | MCF-7 Breast | 207 / 16902 (1.2%) | 8142 / 169020 (4.8%) | −137.1 | −135.2 | 0.25 |
| EZH2 SRX317569 | iPS cells Pluripotent stem cell | 1391 / 16902 (8.2%) | 6345 / 169020 (3.8%) | −137.0 | −135.2 | 2.19 |
| PSIP1 SRX1293534 | MV-4-11 Blood | 860 / 16902 (5.1%) | 2987 / 169020 (1.8%) | −136.9 | −135.0 | 2.88 |
| CBX7 SRX6370188 | NT2-D1 Pluripotent stem cell | 556 / 16902 (3.3%) | 1373 / 169020 (0.8%) | −136.4 | −134.5 | 4.05 |
| Epitope tags SRX7276679 | 293 Kidney | 1845 / 16902 (10.9%) | 9562 / 169020 (5.7%) | −136.3 | −134.5 | 1.93 |
| SMARCA4 SRX4193368 | 22Rv1 Prostate | 1080 / 16902 (6.4%) | 4328 / 169020 (2.6%) | −136.2 | −134.4 | 2.50 |
| JUN SRX6582165 | BJ-5ta Epidermis | 761 / 16902 (4.5%) | 16665 / 169020 (9.9%) | −136.0 | −134.1 | 0.46 |
| FOXL2 SRX5342375 | SVOG-3e Gonad | 312 / 16902 (1.8%) | 9913 / 169020 (5.9%) | −135.8 | −133.9 | 0.31 |
| FOXA1 SRX190181 | A549 Lung | 291 / 16902 (1.7%) | 9560 / 169020 (5.7%) | −135.7 | −133.9 | 0.30 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 332 / 16902 (2.0%) | 10236 / 169020 (6.1%) | −135.7 | −133.9 | 0.32 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 258 / 16902 (1.5%) | 8986 / 169020 (5.3%) | −135.4 | −133.6 | 0.29 |
| NR3C1 SRX10977372 | A549 Lung | 224 / 16902 (1.3%) | 8392 / 169020 (5.0%) | −135.4 | −133.5 | 0.27 |
| TEAD1 SRX3401272 | MCF-7 Breast | 314 / 16902 (1.9%) | 9920 / 169020 (5.9%) | −135.1 | −133.2 | 0.32 |
| Epitope tags SRX4192709 | MDA-MB-231 Breast | 551 / 16902 (3.3%) | 1362 / 169020 (0.8%) | −135.0 | −133.2 | 4.05 |
| FOXA1 SRX028634 | MCF-7 Breast | 201 / 16902 (1.2%) | 7968 / 169020 (4.7%) | −134.9 | −133.1 | 0.25 |
| DNA-RNA hybrid SRX14756935 | MDA-MB-436 Breast | 544 / 16902 (3.2%) | 1330 / 169020 (0.8%) | −134.9 | −133.0 | 4.09 |
| FOXA1 SRX3931043 | MCF-7 Breast | 418 / 16902 (2.5%) | 11576 / 169020 (6.8%) | −134.7 | −132.9 | 0.36 |
| ISL1 SRX16495323 | SK-N-SH Neural | 83 / 16902 (0.5%) | 5614 / 169020 (3.3%) | −134.4 | −132.6 | 0.15 |
| FOXA1 SRX1787655 | MCF-7 Breast | 205 / 16902 (1.2%) | 8023 / 169020 (4.7%) | −134.4 | −132.6 | 0.26 |
| ESR1 SRX1531791 | MCF-7 Breast | 420 / 16902 (2.5%) | 11591 / 169020 (6.9%) | −134.4 | −132.5 | 0.36 |
| FOXA1 SRX190282 | A549 Lung | 286 / 16902 (1.7%) | 9411 / 169020 (5.6%) | −133.8 | −131.9 | 0.30 |
| CEBPA SRX2630241 | Hep G2 Liver | 491 / 16902 (2.9%) | 12658 / 169020 (7.5%) | −133.8 | −131.9 | 0.39 |
| KDM5A SRX23740430 | SUM 149PT Breast | 1585 / 16902 (9.4%) | 7764 / 169020 (4.6%) | −133.7 | −131.9 | 2.04 |
| Epitope tags SRX14024876 | Mesenchymal stem cells Others | 2105 / 16902 (12.5%) | 11564 / 169020 (6.8%) | −133.7 | −131.9 | 1.82 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 192 / 16902 (1.1%) | 7762 / 169020 (4.6%) | −133.6 | −131.8 | 0.25 |
| Epitope tags SRX2255895 | 293 Kidney | 926 / 16902 (5.5%) | 3425 / 169020 (2.0%) | −133.5 | −131.7 | 2.70 |
| ESR1 SRX7624157 | MCF-7 Breast | 1055 / 16902 (6.2%) | 20559 / 169020 (12.2%) | −133.5 | −131.7 | 0.51 |
Showing first 500 of 18350 rows.